Publishing research using ab33478? Please let us know so that we can cite the reference in this datasheet.

ab33478 has been referenced in 9 publications.

  • Li D  et al. Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality. Sci Rep 6:31002 (2016). PubMed: 27481535
  • O'Carroll C  et al. Identification of a unique hybrid macrophage-polarization state following recovery from lipopolysaccharide tolerance. J Immunol 192:427-36 (2014). PubMed: 24337373
  • Chionh YT  et al. Protease-activated receptor 1 suppresses Helicobacter pylori gastritis via the inhibition of macrophage cytokine secretion and interferon regulatory factor 5. Mucosal Immunol N/A:N/A (2014). Mouse . PubMed: 24866378
  • Polioudakis D  et al. A Myc-microRNA network promotes exit from quiescence by suppressing the interferon response and cell-cycle arrest genes. Nucleic Acids Res 41:2239-54 (2013). PubMed: 23303785
  • He H  et al. Immobilized heavy chain-hyaluronic acid polarizes lipopolysaccharide-activated macrophages toward M2 phenotype. J Biol Chem 288:25792-803 (2013). PubMed: 23878196
  • Pandey AK  et al. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 5:e1000500 (2009). WB ; Mouse . PubMed: 19578435
  • Watanabe T  et al. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J Clin Invest 118:545-59 (2008). WB ; Human . PubMed: 18188453
  • Ye L  et al. Methamphetamine enhances Hepatitis C virus replication in human hepatocytes. J Viral Hepat 15:261-70 (2008). PubMed: 18307590
  • Barro M & Patton JT Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J Virol 81:4473-81 (2007). PubMed: 17301153

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"